Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-15

Clinical Trial Update: Kaiser Permanente VACCination Improvement With Nudge-based CardiovAscular Targeted Engagement [NA]

View source ↗

Summary

Kaiser Permanente is evaluating a nudge-based targeted engagement intervention to improve vaccination uptake related to cardiovascular health and influenza.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Cardiovascular Diseases, Influenza | NA | Status: ACTIVE_NOT_RECRUITING